MiR-106a is an independent prognostic marker in patients with glioblastoma.

MiR-106a is an independent prognostic marker in patients with glioblastoma.

Item
http://www.wikidata.org/entity/Q36865988
Integrated analysis of microRNA-target interactions with clinical outcomes for cancersDecreased miR-106a inhibits glioma cell glucose uptake and proliferation by targeting SLC2A3 in GBM.Circulating miR-106a is a Novel Prognostic and Lymph Node Metastasis Indicator for Cholangiocarcinoma.miRNA-148a serves as a prognostic factor and suppresses migration and invasion through Wnt1 in non-small cell lung cancer.MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.The effects of CD147 on the cell proliferation, apoptosis, invasion, and angiogenesis in glioma.MiR-212-3p inhibits glioblastoma cell proliferation by targeting SGK3.MiR-106a targets Mcl-1 to suppress cisplatin resistance of ovarian cancer A2780 cells.MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma.Low serum level of miR-485-3p predicts poor survival in patients with glioblastoma.Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.
P2860

MiR-106a is an independent prognostic marker in patients with glioblastoma.

Item
http://www.wikidata.org/entity/Q36865988
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
MiR-106a is an independent prognostic marker in patients with glioblastoma.
@en
type
label
MiR-106a is an independent prognostic marker in patients with glioblastoma.
@en
prefLabel
MiR-106a is an independent prognostic marker in patients with glioblastoma.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932
P356
P1433
P1476
MiR-106a is an independent prognostic marker in patients with glioblastoma.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P932